Repligen
RGEN
#1858
Rank
โ‚ฌ9.94 B
Marketcap
155,50ย โ‚ฌ
Share price
2.97%
Change (1 day)
23.37%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2023 (TTM): 1,94ย โ‚ฌ

According to Repligen 's latest financial reports the company's current EPS (TTM) is -0,18ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 3,01ย โ‚ฌ an increase over its 2021 EPS that were of 2,10ย โ‚ฌ.

EPS history for Repligen from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)1,94ย โ‚ฌ-35.56%
20223,01ย โ‚ฌ43.59%
20212,10ย โ‚ฌ105.26%
20201,02ย โ‚ฌ153.33%
20190,40ย โ‚ฌ18.42%
20180,34ย โ‚ฌ-47.95%
20170,65ย โ‚ฌ108.57%
20160,31ย โ‚ฌ20.69%
20150,26ย โ‚ฌ16%
20140,22ย โ‚ฌ-48.98%
20130,44ย โ‚ฌ6.52%
20120,41ย โ‚ฌ-512.88%
2011-0,09986ย โ‚ฌ-1214.13%
20100,008963ย โ‚ฌ-106.25%
2009-0,14ย โ‚ฌ-200%
20080,14ย โ‚ฌ-87.79%
20071,17ย โ‚ฌ-2283.33%
2006-0,05378ย โ‚ฌ-300%
20050,02689ย โ‚ฌ-115%
2004-0,18ย โ‚ฌ-25.93%
2003-0,24ย โ‚ฌ80%
2002-0,13ย โ‚ฌ-21.05%
2001-0,17ย โ‚ฌ-0%
2000-0,17ย โ‚ฌ-12.14%
1999-0,19ย โ‚ฌ245.01%
1998-0,05618ย โ‚ฌ33.33%
1997-0,04213ย โ‚ฌ-87.18%
1996-0,33ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,68ย โ‚ฌ-480.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
17,02ย โ‚ฌ-9,595.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
7,82ย โ‚ฌ-4,465.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,05ย โ‚ฌ-2,360.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-0,34ย โ‚ฌ 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-1,36ย โ‚ฌ 660.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
6,32ย โ‚ฌ-3,625.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
1,05ย โ‚ฌ-685.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
0,34ย โ‚ฌ-290.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-4,34ย โ‚ฌ 2,320.00%๐Ÿ‡บ๐Ÿ‡ธ USA